Home › Funds › Vestal Point Capital, LP › ZBIO

Vestal Point Capital, LP position in ZBIO

ZENAS BIOPHARMA INC · Health Care

Vestal Point Capital, LP reported holding 395,000 shares of ZBIO (ZENAS BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$10.7M, representing 0.28% of its reported portfolio and ranking #37 among its reported holdings. Vestal Point Capital, LP has disclosed ZBIO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)395.00K sh
Reported value held$10.65M
Portfolio Weight0.28%
First reportedQ1 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's ZBIO position evolved

Vestal Point Capital, LP first disclosed a stake in ZBIO in Q1 2026 at 200,000 shares (US$3.9M). The position peaked in Q3 2026 at 395,000 shares, worth US$10.7M. Across 3 filings, Vestal Point Capital, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 395,000 shares valued at US$10.7M — an increase of 30,000 shares quarter over quarter.. Notable position changes include a 82% increase in Q2 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 200.00K $3.91M New
Q2 2026 365.00K $9.26M Add
Q3 2026 395.00K $10.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBIO and 13F data

ZBIO (ZENAS BIOPHARMA INC) is a Health Care company. 59 other funds we track also report a position in ZBIO — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$135.9M), NEA Management Company, LLC (US$108.5M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$85.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBIO

All ZBIO fund holders →

FAQ

How long has Vestal Point Capital, LP held ZBIO?

Vestal Point Capital, LP has disclosed ZBIO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Vestal Point Capital, LP's current position in ZBIO?

As of Q3 2026, Vestal Point Capital, LP holds 395.00K shares of ZBIO (ZENAS BIOPHARMA INC), valued at $10.65M, representing 0.28% of its reported portfolio and ranking #37.

Has Vestal Point Capital, LP been buying or selling ZBIO?

In the latest 13F filing (Q3 2026), Vestal Point Capital, LP increased its position in ZBIO. The position peaked in Q3 2026 at 395.00K shares.

Which other funds hold ZBIO?

Other major institutional holders of ZBIO include SR ONE CAPITAL MANAGEMENT, LP, NEA Management Company, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.